Advanced Accelerator Applications Usa
UEI: YE3YG1FDWMC5
Overview
Awardee Type
Parent
(3 children)
Company Description
Transforming patients’ lives by leading innovation in nuclear medicine and targeted radioligand therapy for oncology indications. Click to find out more.
Name
Advanced Accelerator Applications Usa
Headquarters
Millburn, NJ
United States
United States
Most Recent Award
April 11, 2025
Calculating
Federal contract and grant recipient
ADVANCED ACCELERATOR APPLICATIONS USA INC
(UEI YE3YG1FDWMC5)
is headquartered in Millburn NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in July 2001 and
federally registered in
January 2004.
Federal Award Analysis
Advanced Accelerator Applications Usa federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI JNM4NBNHFE66 CAGE 3PTH3 instead.
Legal Name
ADVANCED ACCELERATOR APPLICATIONS USA INC
UEI
JNM4NBNHFE66
CAGE Code
3PTH3
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 16, 2001
Initial Registration
Jan. 15, 2004
Last Registration
Aug. 28, 2024
Registration Activation
May 27, 2024
Registration Expiration
May 23, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Advanced Accelerator Applications Usa
GSA Schedules and Price Lists
- Novartis Gene Therapies
- PoP: 9/14/20 - 9/14/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Novartis Pharmaceuticals Corporation
- PoP: 8/31/20 - 8/31/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $6,813,414
- Novartis Gene Therapies
- PoP: 10/2/19 - 9/2/20 (Ended)
- Advanced Accelerator Applications Usa
- PoP: 6/14/19 - 1/31/25 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $82,017,796
- Novartis Pharmaceuticals Corporation
- PoP: 9/30/13 - 8/31/20 (Ended)
- Obligated: $3,048,650